ROTTERDAM, Netherlands, January 30, 2009 –LyondellBasell Industries has become the first polyolefins supplier worldwide to establish a global business team exclusively dedicated to addressing the specialized needs of healthcare applications. The new organization, which includes global business management, global technical services, and regional sales teams located in the Americas, Europe, AFMEI and Asia Pacific, is fully operational.
Global asset footprint, local supply
Most leading medical and pharmaceutical companies have production sites throughout the world, and require material consistency from locally-sourced materials within regional markets. Following the merger of Basell and Lyondell, the new company has strategically-located supply facilities that target uniformity of specifications, no matter where customers are located.
"In the past, we have always supplied our European-produced resins on a global basis," said Jochen Schneider, Head of LyondellBasell’s Healthcare Applications business unit. "Now, our expanded global asset footprint enables us to produce LyondellBasell’s high-quality Purell resins in the regions where it fits best for our customers. With production locations in the major regions of the world, we are able to effectively address customer needs, and at the same time reduce emissions and environmental impact by utilizing shorter transportation routes for shipments."
The new team builds upon the success of LyondellBasell’s portfolio of Purell polyethylene and polypropylene resins that feature characteristics such as consistent formulation, long-term supply, customized logistics and pharmacopoeia compliance certificates.
Regulatory changes addressed
Customers in the healthcare industry will also benefit from LyondellBasell’s knowledgeable local sales and technical service teams dedicated to medical and pharmaceutical applications.
"Our new Global Key Account management team is equipped to address the specific needs of this highly sensitive industry," explained Dr. Michael Luetke, Global Marketing Manager of LyondellBasell’s Healthcare Applications business unit. "With more than 30 years of experience in healthcare applications, our team is highly skilled in technical as well as regulatory aspects."
The new business team interacts directly with Manufacturing, Regulatory Affairs, and Product Safety and Quality Control activities to ensure that any changes made to regulatory requirements can be implemented as quickly as possible.
# # #
LyondellBasell Industries is one of the world’s largest polymers, petrochemicals and fuels companies. We are the global leader in polyolefins technology, production and marketing; a pioneer in propylene oxide and derivatives; and a significant producer of fuels and refined products, including biofuels. Through research and development, LyondellBasell develops innovative materials and technologies that deliver exceptional customer value and products that improve quality of life for people around the world. Headquartered in The Netherlands, LyondellBasell (www.lyondellbasell.com) is privately owned by Access Industries.
Contact:
Media - Waldemar Oldenburger, LyondellBasell Industries
Tel: +49 69 305 854 59
waldemar.oldenburger@lyondellbasell.com
For additional information on healthcare applications, contact:
Dr. Michael Luetke, Global Marketing Manager, Healthcare Applications
Tel: +496930515724
michael.luetke@lyondellbasell.com